Access cutting-edge metastatic breast cancer treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access metastatic breast cancer specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related metastatic breast cancer treatment provided free
The researchers are doing this study to find out if the study drug, enzalutamide, alone or combined with the study drug, mifepristone, is effective in treating advanced or metastatic androgen receptor-positive (AR+) triple negative breast cancer (TNBC) or estrogen receptor-low breast cancer (ER-low BC), and whether these study treatments work as well as standard chemotherapy with carboplatin, paclitaxel, capecitabine, or eribulin.
Sponsor: Memorial Sloan Kettering Cancer Center
Check if you qualify for this metastatic breast cancer clinical trial in Birmingham, AL
If you're searching for metastatic breast cancer treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced metastatic breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.